Impact of Racial Differences in Alzheimer Biomarkers


Cerebral impairment in older African Americans is related with smaller changes in cerebrospinal fluid (CSF) tau biomarkers but greater influence from white matter hyperintensity (WMH) burden compared with impairment in older white Americans, according to a study from Emory University in Atlanta, Georgia.

These race-associated variance in CSF tau markers may result in underdiagnosis of Alzheimer disease(AD) in African Americans, according to the researchers. This is the primary research to directly look at race, CSF AD biomarker levels, and the relationships between WMH and cognition.      

Background

The research team noted that the occurrence of AD is nearly doubled in African Americans compared with whites. Although African Americans also reportedly are more likely than whites to have nonamnestic forms of mild cognitive impairment (MCI) and slower decay to and through dementia, postmortem studies show that they have greater ischemia, which is related with WMH burden, and Lewy body copathology.                                                         

Study design

The Emory team assumed that CSF amyloid biomarkers, dysfunction and neurodegeneration would differ between older black and white Americans with normal understanding and AD-associated cerebral impairment. They prospectively involved older black and white Americans with either normal thought, MCI, or AD to explore race-related alterations in efforts to improve the classification of AD and non-AD pathology in older African Americans. A total of 66 older black and 72 older white Americans (average age, 70 years for both cohorts) were registered in the study and underwent detailed clinical, neuropsychological, MRI, genetic, and CSF analyses. Aβ40 and Aβ42, tau, neurodegenerative and candidate endothelial markers, and soluble intercellular cell adhesion molecule 1 were characterized to test their association with cerebral impairment within each race.


Comments

Post a Comment

Popular posts from this blog

The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia.

Image
Sickle cell disease (SCD) is one of the most common autosomal recessive diseases in humans, occurring at a frequency of 1 in 365 African-American and 1 in 50 sub-Saharan African births. Despite progress in managing complications of SCD, these remain a major health burden worldwide. Stroke is a common and serious complication of SCD, most often associated with steno-occlusive cerebral arteriopathy, but little is known about its pathogenesis. Transcranial Doppler ultrasonography is currently the only predictive test for the future development of stroke in patients with sickle cell anemia and is used to guide preventative treatment. However, transcranial Doppler ultrasonography does not identify all patients at increased risk for stroke, and progressive arteriopathy may occur despite preventative treatment. While sibling studies have shown a strong genetic contribution to the development of steno-occlusive arteriopathy (SOA) in SCD, the only genome-wide association study
Read more

Does Variability of Brain Blood Flow Increase Stroke Risk in Stroke Survivors and After TIA?

Image
Stroke is the second leading cause of death worldwide, and high blood pressure (BP) is the most important treatable factor that increases a person’s risk of having a stroke. Stiffness of the blood vessels supplying the brain (arterial stiffness), possibly due to long-standing raised BP, is also likely to be a factor that increases stroke risk. Such increased arterial stiffness results in the blood flow through these vessels being more pulsatile (throbs faster) than usual, and this increased pulsatility can be assessed by an ultrasound scan. This research is focused on assessing the relationship between the pulsatility of the blood flow through the blood vessels supplying the brain, and the risk of stroke in patients who have already had a stroke or “mini-stroke” in the past, and in particular to see if this relationship can be explained by raised BP alone. The Oxford Vascular Study (OXVASC) recruits all patients with stroke or “ mini-stroke ” from a single population,
Read more

Vitamin D and hypertension

Image
Vitamin D, a fat-soluble prohormone, has wide-ranging roles in the regulation of many physiological processes through their interactions with the vitamin D receptors (VDR). It plays a major role in bones and calcium metabolism. Vitamin D deficiency is not uncommon and it has been associated with many health-related issues, including skeletal and non-skeletal complications. The association of low vitamin D and cardiovascular diseases and risk factors has been explored in both animal and human studies. However, studies and trials on the effect of vitamin D supplementation on cardiovascular risk factors and hypertension are conflicting with inconsistent results. Therefore, large, well-powered randomized controlled trials are warranted. If successful, supplementation with easy and low-cost vitamin D can impact our health positively. Here, we summarized the evidence for the association of vitamin D, cardiovascular diseases and risk factors, including coronary artery diseases,
Read more